Investment Rating - The report maintains a "Buy" investment rating for Ximai Food (002956.SZ) [8] Core Insights - The company's total operating revenue for Q1-Q3 2025 reached 1.696 billion yuan, representing an 18% year-on-year increase, while the net profit attributable to shareholders was 132 million yuan, up 22% year-on-year [1] - The gross profit margin for Q3 2025 increased by 1 percentage point to 43.75%, driven by product structure optimization and a decrease in raw material costs [2] - The launch of the medicinal food series in September received positive feedback, with a focus on market testing and consumer feedback collection in Q4 2025 [3] Financial Performance - For Q3 2025, total operating revenue was 547 million yuan, a 19% increase year-on-year, and the net profit attributable to shareholders was 51 million yuan, up 21% year-on-year [1] - The company has locked in raw material prices for the year, and costs are expected to continue declining, which will support sustained gross margin improvements [2] - The adjusted earnings per share (EPS) forecasts for 2025-2027 are 0.77, 1.02, and 1.27 yuan, respectively, with corresponding price-to-earnings (PE) ratios of 28, 21, and 17 times [8] Market Position and Strategy - Ximai Food is focusing on the oat category, with a strong emphasis on the health strategy, which is progressing smoothly [4] - The online sales channel continues to show rapid growth while maintaining cost control, and the company is expected to improve channel profitability further [3] - The company is adapting its product offerings in response to market conditions, including the introduction of new high-protein oat products in various retail channels [3]

Group 1 - The company has appointed a new general manager, Sun Hongyan, who has been with the company for 20 years and is familiar with its operations and the fast-moving consumer goods market. The change in management will not significantly impact the company's future strategic planning [1] - The main growth driver for the company in recent years has been composite oats, with new product launches such as medicinal food series powders and Seven White Eight Treasure oat flakes meeting consumer demand for traditional Chinese health products. The sales performance has been good, and more similar products will be launched in the future [2] - The product structure has shifted due to the rapid growth of composite oats, which have a complex processing method and higher added value, leading to an overall increase in the company's gross margin. Additionally, a decrease in raw material costs has also contributed to the improvement in gross margin [2] Group 2 - The company continues to focus on oat-related products, with pure oats maintaining stable and sustainable growth. Pure oats are considered a foundational product with future growth potential [3] - Resources have been increasingly allocated to composite oats, which are made by adding various ingredients to pure oats. The performance of composite oats has met the company's expectations, driving overall growth and profitability [3] - In the medium to short term, the company will continue its product development strategy, incorporating traditional medicinal ingredients such as red dates, ginseng, tremella, and bird's nest into pure oats under the guidance of traditional Chinese health concepts [3]

Investment Rating - The investment rating for the company is "Outperform" (Maintain) [1] Core Views - The company has shown strong revenue growth momentum, with a 2025 H1 revenue of 1.15 billion yuan, representing a year-on-year increase of 18.1%. The net profit attributable to the parent company reached 80 million yuan, up 22.5% year-on-year [4][5] - The company is expected to benefit from the expansion of its oat product lines and a downward trend in raw material costs over the next 2-3 years, maintaining good growth elasticity in revenue and profit [4][5] - The company is actively developing its health product segment, with new products expected to drive additional growth [5] Financial Performance Summary - In 2025 Q2, the company achieved a revenue of 490 million yuan, a year-on-year increase of 21.0%, and a net profit of 27 million yuan, up 25.2% year-on-year [4][5] - The company's gross margin improved by 2.64 percentage points to 43.50% in Q2 2025, primarily due to a decrease in raw material costs [7] - The projected net profit for 2025-2027 is expected to be 170 million yuan, 220 million yuan, and 260 million yuan, respectively, with year-on-year growth rates of 29.5%, 28.7%, and 19.0% [4][8] Product and Channel Development - The company has seen a strong growth trend in its composite oat products, with a growth rate exceeding 35%, which is a key growth driver [5] - Online sales have grown over 40% in Q2 2025, with platforms like Douyin showing particularly strong performance [6] - The company is expanding its offline channels, with emerging channels such as snack wholesale and instant retail showing good growth [6] Cost and Profitability Metrics - The sales expense ratio increased significantly in Q2 2025, reflecting the company's strategy to invest in market opportunities [7] - The net profit margin slightly increased by 0.28 percentage points to 5.54% in Q2 2025 [7] - The company’s projected EPS for 2025 is 0.77 yuan, with corresponding P/E ratios of 28.2, 22.0, and 18.4 for 2025, 2026, and 2027, respectively [8]